ERBB2 and breast carcinoma: They also evaluated the percentage of TLSs positivity in all molecular subtypes of breast cancer.Luminal B breast cancer subtype had a high percentage of TLSs positive cases among Luminal subtypes 27.58% followed by Luminal A-BC (24.13%) and Luminal B-HER2 (10.34%) (109).